News
 

In a recent study published in Scientific Reports, researchers from China used Mendelian randomization (MR) to assess the genetic relationship between body mass index (BMI) and multiple neurological diseases.

This new study published in Nature Communicatios pinpoints a brain network that is crucially impacted by aging and diseases such as schizophrenia and Alzheimer's, showing increased susceptibility to specific lifestyle and environmental factors.

Exposure to more traffic-related air pollution is associated with greater levels of amyloid plaques in the brain, with exposure in the 3 years before death having the greatest risk, a new postmortem study showed.

A new study found Kundalini yoga provided several benefits to cognition and memory for older women at risk of developing Alzheimer's disease including restoring neural pathways, preventing brain matter decline and reversing aging and inflammation-associated biomarkers -- improvements not seen in a group who received standard memory training...

Researchers have found that brain cell activity during sleep is responsible for propelling fluid into, through and out of the brain, cleaning it of debris.

The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, researchers have found. In a new study (Nature, 2024; DOI: 10.1038/s41586-024-07130-8), researchers showed that vaccines injected into the eyes of mice can help disable the herpes virus,...

Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released March 6, 2024. The study will be presented at the American Academy of Neurology's 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and...

Patients with multiple sclerosis (MS) have almost double the risk for seizures, with the risk even greater with sphingosine-1-phosphate receptor (S1PR) modulators, results of a new meta-analysis of randomized controlled trials (RCTs) suggest.

Migraine, a common comorbidity in multiple sclerosis (MS) is not part of the MS prodrome, new research suggested.

When evaluated at 3 or 12 months, serum neurofilament light chain (sNfL) levels were predictive of new or enlarging T2 lesions in patients with multiple sclerosis (MS) regardless of treatment assignment, new sub-study data from the ASCLEPIOS I/II trials showed.